학술논문
'학술논문'
에서 검색결과 201건 | 목록
1~10
Academic Journal
Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.; Joerger M; Department of Medical Oncology & Hematology, Cantonal Hospital, St. Gallen, Switzerland. Electronic address: markus.joerger@kssg.ch.; Bang YJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.; Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.; Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Gandara D; Division of Hematology-Oncology, University of California, Davis, 4501 X Street, Suite, 3016, Sacramento, CA, USA.; Stahl M; Department of Medical Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.; Monk BJ; GOG-Foundation, University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, USA.; Jaehde U; Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn.; Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: beumerj@gmail.com.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Editorial & Opinion
Peeters SL; Department of Clinical Pharmacy, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Thijs AM; Department of Medical Oncology, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.; Hulshof EC; Department of Clinical Pharmacy, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE
Editorial & Opinion
Hulshof EC; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; de With M; Department of Medical Oncology, Erasmus University Medical Centre, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: maarten.deenen@catharinaziekenhuis.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
van Erp NP; Eechoute K; van der Veldt AA; Haanen JB; Reyners AK; Mathijssen RH; Boven E; van der Straaten T; Baak-Pablo RF; Wessels JA; Guchelaar HJ; Gelderblom H; van Erp, Nielka P; Eechoute, Karel; van der Veldt, Astrid A; Haanen, John B; Reyners, An K L; Mathijssen, Ron H J; Boven, Epie; van der Straaten, Tahar
Journal of Clinical Oncology; 9/10/2009, Vol. 27 Issue 26, p4406-4412, 7p
Academic Journal
Sparreboom A; Wolff AC; Mathijssen RH; Chatelut E; Rowinsky EK; Verweij J; Baker SD; Sparreboom, Alex; Wolff, Antonio C; Mathijssen, Ron H J; Chatelut, Etienne; Rowinsky, Eric K; Verweij, Jaap; Baker, Sharyn D
Journal of Clinical Oncology; 10/20/2007, Vol. 25 Issue 30, p4707-4713, 7p
Academic Journal
van der Bol JM; Mathijssen RH; Loos WJ; Friberg LE; van Schaik RH; de Jonge MJ; Planting AS; Verweij J; Sparreboom A; de Jong FA; van der Bol, Jessica M; Mathijssen, Ron H J; Loos, Walter J; Friberg, Lena E; van Schaik, Ron H N; de Jonge, Maja J A; Planting, André S Th; Verweij, Jaap; Sparreboom, Alex; de Jong, Floris A
Journal of Clinical Oncology; 7/1/2007, Vol. 25 Issue 19, p2719-2726, 8p
Academic Journal
Goey AK; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.; Agema BC; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.; Hoop EO; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Singh RK; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; van der Veldt AA; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.; Mathijssen RH; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; van Schaik RH; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.; Bins S; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE
Academic Journal
van der Bol JM; Visser TJ; Loos WJ; de Jong FA; Wiemer EA; van Aken MO; Planting AS; Schellens JH; Verweij J; Mathijssen RH; van der Bol, Jessica M; Visser, Theo J; Loos, Walter J; de Jong, Floris A; Wiemer, Erik A C; van Aken, Maarten O; Planting, Andre S; Schellens, Jan H; Verweij, Jaap; Mathijssen, Ron H J
Academic Journal
Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Chu E; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Allegra C; University of Florida, Gainesville, Florida, USA.; Tanigawara Y; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan.; Milano G; Oncopharmacology Unit, Centre Antoine Lacassagne, Nice, France.; Diasio R; Developmental Therapeutics Program, Mayo Clinic Cancer Center, Rochester, Minnesota, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.; Kim TW; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Arnold D; Department of Oncology, AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.; Muneoka K; Division of Oncology Center, Niitsu Medical Center Hospital, Niigata City, Japan.; Boku N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan.; Joerger M; Department of Medical Oncology & Hematology, Cantonal Hospital, St. Gallen, Switzerland.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Editorial & Opinion
Versmissen J; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Center.; van Doorn L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Mirabito Colafella KM; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Center.; Cardiovascular Program, Monash Biomedicine Discovery Institute.; Department of Physiology, Monash University, Melbourne, Australia.; Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Danser AHJ; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Center.
Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 8306882 Publication Model: Print Cited Medium: Internet ISSN: 1473-5598 (Electronic) Linking ISSN: 02636352 NLM ISO Abbreviation: J Hypertens Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Mathijssen RH
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어